Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 146 Head and Neck Neoplasms 80 Squamous Cell Carcinoma of Head and Neck 69 Rectal Neoplasms 46 Colonic Neoplasms 42 Carcinoma, Non-Small-Cell Lung 39 Neoplasm Metastasis 35 Neoplasms 25 Carcinoma, Squamous Cell 20 Pancreatic Neoplasms 17 Lung Neoplasms 16 Esophageal Neoplasms 15 Stomach Neoplasms 12 Recurrence 11 Laryngeal Neoplasms 11 Mouth Neoplasms 10 Oropharyngeal Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Breast Neoplasms 8 Adenocarcinoma Of Esophagus 8 Tongue Neoplasms 7 Uterine Cervical Neoplasms 6 Nasopharyngeal Carcinoma 6 Laryngeal Diseases 6 Hypopharyngeal Neoplasms 6 Colorectal Cancer Metastatic 6 Carcinoma 6 Adenocarcinoma of Lung 6 Salivary Gland Neoplasms 5 Cholangiocarcinoma 4

Interventions

Bevacizumab 23 Sorafenib 20 Doxorubicin 14 Gemcitabine 11 durvalumab 10 Oxaliplatin 10 Fluorouracil 10 Cisplatin 10 Capecitabine 9 Nivolumab 8 pembrolizumab 6 Sunitinib 6 tremelimumab 5 atezolizumab 5 Radiofrequency Ablation 5 Neoadjuvant Therapy 5 Leucovorin 5 lenvatinib 4 aldesleukin 4 Thalidomide 4 Radiotherapy 4 Radiosurgery 4 Everolimus 4 Erlotinib Hydrochloride 4 Drug Therapy 4 Carboplatin 4 toripalimab 3 regorafenib 3 camrelizumab 3 apatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Neoplasms × Cetuximab × Clear all

NCT00483405 2017-07-12

NRR

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed

33 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡